Job Description
CEO & Co-Founder Opportunity – ENDOMET (The Collider Programme)
Granada, Spain – Call4Entrepreneurs – The Collider
About the role
ENDOMET, a deep‑tech biotech project backed by the University of Granada, is developing MVP11, a first‑in‑class small molecule that restores mitochondrial energy by activating endogenous Coenzyme Q (CoQ) biosynthesis. The project is seeking an entrepreneurial CEO to join the founding team and lead the creation of the spin‑off. The CEO will be responsible for guiding the team through the initial stages of company formation, strategy development, and product development, and will play a pivotal role in positioning ENDOMET as a leading mitochondrial energy platform.
About ENDOMET
A large number of frequent and rare diseases are characterized by CoQ deficiency, leading to impaired mitochondrial energy production. Current standard care relies on exogenous CoQ10 supplementation, which underperforms due to poor bioavai...